Reuters logo
BRIEF-Roivant Sciences partners with AstraZeneca for drug development
2017年10月19日 / 下午1点22分 / 1 个月前

BRIEF-Roivant Sciences partners with AstraZeneca for drug development

Oct 19 (Reuters) - AstraZeneca Plc

* Roivant Sciences says entered into a development partnership with AstraZeneca for a deprioritized investigational drug in an undisclosed indication​

* Deal terms of partnership include an upfront payment, development milestones, and royalties Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below